FitAdhere: A Mobile Health Platform Supporting Adherence to Protocol-Based Therapeutic Exercise
Studies in Health Technology and Informatics · 21.05.2026
DOI: 10.3233/shti260592 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Studies in Health Technology and Informatics, erschienen am 21.05.2026. Verfasst von George Tsalkitzis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digital Systems, University of Piraeus, Greece. Hauptthemen laut MEDLINE: Exercise Therapy, Mobile Applications, Patient Compliance. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
According to the World Health Organization, regular physical activity is essential for the prevention and management of major noncommunicable diseases and for supporting health in specific physiological conditions such as pregnancy. In Greece, the Central Council of Health provides evidence-based therapeutic exercise protocols for several conditions, including diabetes and osteoporosis. This poster presents FitAdhere, a mobile health application that facilitates monitoring and management of exercise routines in alignment with these protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Digital Systems, University of Piraeus, Greece.
Zitieren
APA
Tsalkitzis, G., & Koufi, V. (2026). FitAdhere: A Mobile Health Platform Supporting Adherence to Protocol-Based Therapeutic Exercise. Studies in Health Technology and Informatics. https://doi.org/10.3233/shti260592
Vancouver
Tsalkitzis G, Koufi V. FitAdhere: A Mobile Health Platform Supporting Adherence to Protocol-Based Therapeutic Exercise. Studies in Health Technology and Informatics. 2026. doi:10.3233/shti260592
BibTeX
@article{Tsalkitzis2026,
author = {Tsalkitzis, George and Koufi, Vassiliki},
title = {FitAdhere: A Mobile Health Platform Supporting Adherence to Protocol-Based Therapeutic Exercise},
journal = {Studies in Health Technology and Informatics},
year = {2026},
doi = {10.3233/shti260592}
}
EUVIMED